Acadia Pharmaceuticals
ACAD
ACAD
294 hedge funds and large institutions have $2.99B invested in Acadia Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 108 increasing their positions, 74 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
294
Holders Change
+39
Holders Change %
+15.29%
% of All Funds
3.92%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
70
Increased
108
Reduced
74
Closed
29
Calls
$18.4M
Puts
$7.74M
Net Calls
+$10.6M
Net Calls Change
+$1.01M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$134M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$40.9M |
| 3 |
3
SG Americas Securities
New York
|
$45.6M |
| 4 |
4
Citigroup
New York
|
$30.6M |
| 5 |
5
Goldman Sachs
New York
|
$52.9M |
